logo

  • SELECT LICENSE :

  • US $4,299.00
  • US $8,599.00

Home Healthcare Market, By Component (Services (Rehabilitation, Pregnancy, Palliative), Equipment (BO, Monitors, HIV Test Kit, Pregnancy Test Kit), Software, opportunities and forecast 2020-2027

  • DLR2119
  • 20 September, 2020
  • Pharma & Healthcare
  • Pages: 120
  • Global
Market Overview

Population aging across the world coupled with increased patient inclination towards value-based healthcare are expected to fuel the market growth. According to World Health Organization (WHO), there were approximately 703 million persons aged over 65 years in 2019. The number of elder persons is likely to double to 1.5 billion by the year 2050. The aging population demands the extra patient-centric services that in turn increases demand for the home healthcare agencies and workers this is estimated to drive the growth of the home healthcare market.

The Bureau of Labor Statistics (BLS) states that growing workforce relating to healthcare service interprets the increasing demand for various home health and private healthcare aides and is likely to outpace healthcare sector’s evolution, with over 4 million jobs only in home healthcare sector. In recent years, the chronic diseases which require long-term action have substituted infections as the principal cause of age-related death, this shift is not restricted to developed world. Treating and managing various chronic illnesses has turn into a major concern. Approximately 50% of home healthcare patients have one chronic illness, and the number is anticipated to keep growing in future. Chronic diseases, that affect older adults, contribute to disabilities, increase long-term care costs, and diminish the quality of life, thus opening range of opportunities for home healthcare companies.

Segment Overview

By component, the market has been segmented into services, equipment, and software. Among the component, the services dominated the market in 2019. With the dramatic surge in aging population worldwide, demand for home healthcare is increasing for the better patient outcomes. Additionally, the increasing occurrence of chronic disease amongst the elderly is another main factor leading to the market growth.

Regional Overview

In North America, held largest market share in 2019 accredited to shifting trends to in-home healthcare from nursing homes, presence of advanced medical infrastructure and technological advancement. Additionally, high patient consciousness levels coupled with the increasing healthcare expenditure and implementation of streamlined regulatory framework are driving the market growth in the region. Furthermore, supportive initiatives by Centers for Medicare and Medicaid Services (CMMS) are projected to propel the market growth.

Germany followed by France held largest market share in the Europe in 2019. This is largely due to the increasing expenditure in home healthcare in the country and the growing demand for skilled nursing workforce for the in-house care.

Competitor overview

The contributors to the market are divided as service providers, manufacturers, and software solution providers. Key manufacturers in the market include McKesson Medical-Surgical Inc.; Medline Industries, Inc.; Fresenius Medical Care; Medtronic PLC; Baxter International Inc.; 3M Healthcare; B. Braun Melsungen AG; F. Hoffmann-La Roche AG; Arkray, Inc.; Becton, Dickinson And Company; Acelity L.P.; ConvaTec Group PLC; Hollister Inc.; and Molnlycke Health Care.
The key service providers include Home Health Services Ltd.; Brookdale Senior Living, Inc.; Sunrise Carlisle, LP; Care UK Limited; Extendicare, Inc.; Senior Care Centers of America; Sompo Holdings, Inc.; Kindred Healthcare, Inc.; Genesis Healthcare Corp.; and Home Instead Senior Care, Inc.

Key Players
  1. Epic Systems Corporation;
  2. Allscripts Healthcare Solutions, Inc.;
  3. Cerner; Omnicare;
  4. Home Health Services Ltd.;
  5. Sunrise Carlisle, LP;
  6. Extendicare, Inc.;
  7. Care UK Limited;
  8. MatrixCare;
  9. Optimus EMR;
  10. Netsmart;
  11. PointClickCare.

Market Segmentation

By Component
  • Services
    • Rehabilitation,
    • Pregnancy,
    • Palliative
  • Equipment
    • BP & Heart Rate Monitor,
    • Ovulation Kit,
    • HIV Test,
    • ECG,
    • Nebulizer,
    • Hearing Aids,
    • Pedometer,
    • Cane,
    • Crutches,
    • Wheelchair
  • Software
By Geography
  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • UAE
    • Rest of LAMEA


1 Executive Summary 14

    2 Market Introduction 17

    • 2.1 Definition 18
    • 2.2 Scope of the Study 18
    • 2.3 List of Assumptions 19
    • 2.4 Market Structure 19
    • 2.5 Key Takeaways 20
    • 2.6 Key Buying Criteria 20

    3 Research Methodology 21

    • 3.1 Primary Research Methodology 22
    • 3.2 Secondary Research Methodology 23
    • 3.3 Market Share Analysis 23
    • 3.4 Trade Analysis 23
    • 3.5 Market Pricing Approach 24

    4 Market Impact Analysis 25

    • 4.1 Porter’s Five Force Analysis 26
      • 4.1.1 Bargaining Power of Buyer 27
      • 4.1.2 Bargaining Power of Supplier 27
      • 4.1.3 Threat from substitute 27
      • 4.1.4 Threat from a New Entrant 27
      • 4.1.5 Intensity of Competitive Rivalry 28
    • 4.2 Value Chain Analysis 28
      • 4.2.1 Device Manufacturers 28
      • 4.2.2 App Developers 28
      • 4.2.3 Network providers/ Mobile operators 29
      • 4.2.4 Healthcare providers and Pharmaceuticals 29
      • 4.2.5 Patients 29
    • 4.3 Pricing Analysis 29
      • 4.3.1 Cost-effectiveness and patients’ convenience will drive the home healthcare market 29
    • 4.4 Investment Opportunity Analysis 30
      • 4.4.1 Continuous increase in Lifestyle Disease has led to the development of personalized healthcare solutions 30

    5 Market Dynamics 31

    • 5.1 Introduction 32
    • 5.2 Drivers 33
      • 5.2.1 Growing geriatric population 33
      • 5.2.2 Rising treatment cost and hospital stay 34
      • 5.2.3 Technological advancements 35
    • 5.3 Restraints 36
      • 5.3.1 Patients Safety Concerns 36
    • 5.4 Opportunities 37
      • 5.4.1 Rising prevalence of Chronic Disorders 37
      • 5.4.2 Improvement in Reimbursement Scenario 38
    • 5.5 Mega Trends 39
      • 5.5.1 Telemedicine 39
    • 5.6 Macroeconomic Indicators 39
    • 5.7 Technology Trends & Assessment 39

    6 Global Home Healthcare Market by Product 40

    • 6.1 Introduction 41
      • 6.1.1 Testing, Screening, & Monitoring Products 42
      • 6.1.2 Therapeutic Products 43

    7 Global Home Healthcare Market by Services 44

    • 7.1 Introduction 45
      • 7.1.1 Skilled Nursing Services 46
      • 7.1.2 Rehabilitation Therapy Services 46
      • 7.1.3 Unskilled Care Services 46
      • 7.1.4 Respiratory Therapy Services 47
      • 7.1.5 Infusion Therapy Services 47
      • 7.1.6 Pregnancy Care Services 48

    8 Global Home Healthcare Market by Software 49

    • 8.1 Introduction 50
      • 8.1.1 Clinical Management Systems 51
      • 8.1.2 Agency Software 51
      • 8.1.3 Telehealth Solution 51
      • 8.1.4 Hospice Solutions 52

    9 Global Home Healthcare Market by Region 53

    • 9.1 Introduction 54
    • 9.2 Americas 55
      • 9.2.1 North America 59
        • 9.2.1.1 U.S. 61
        • 9.2.1.2 Canada 63
      • 9.2.2 South America 65
    • 9.3 Europe 68
      • 9.3.1 Western Europe 72
        • 9.3.1.1 Germany 74
        • 9.3.1.2 France 77
        • 9.3.1.3 U.K. 79
        • 9.3.1.4 Italy 81
        • 9.3.1.5 Spain 83
        • 9.3.1.6 Rest of Western Europe 85
      • 9.3.2 Eastern Europe 87
    • 9.4 Asia Pacific 90
      • 9.4.1 Japan 94
      • 9.4.2 China 96
      • 9.4.3 India 98
      • 9.4.4 Republic of Korea 100
      • 9.4.5 Australia 102
      • 9.4.6 Rest of Asia-Pacific 104
    • 9.5 Middle East & Africa 107
      • 9.5.1 United Arab Emirates 110
      • 9.5.2 Saudi Arabia 112
      • 9.5.3 Oman 114
      • 9.5.4 Kuwait 116
      • 9.5.5 Qatar 118
      • 9.5.6 Rest of Middle East & Africa 120

    10 Company Landscape 123

    • 10.1 Competitive Landscape 124
    • 10.2 Company Analysis 124
    • 10.3 Company Market Share 124

    11 Company Profiles 125

    • 11.1 Abbott 126
      • 11.1.1 Financials 126
      • 11.1.2 Products 126
      • 11.1.3 Strategy 126
      • 11.1.4 Key Developments 126
    • 11.2 GE Healthcare 127
      • 11.2.1 Financials 127
      • 11.2.2 Products 127
      • 11.2.3 Strategy 127
      • 11.2.4 Key Developments 127
    • 11.3 Becton Dickinson 128
      • 11.3.1 Financials 128
      • 11.3.2 Products 128
      • 11.3.3 Strategy 128
      • 11.3.4 Key Developments 128
    • 11.4 Omron Corporation 129
      • 11.4.1 Financials 129
      • 11.4.2 Products 129
      • 11.4.3 Strategy 129
      • 11.4.4 Key Developments 129
    • 11.5 Apple 130
      • 11.5.1 Financials 130
      • 11.5.2 Products 130
      • 11.5.3 Strategy 130
      • 11.5.4 Key Developments 130
    • 11.6 Medtronic PLC 131
      • 11.6.1 Financials 131
      • 11.6.2 Products 131
      • 11.6.3 Strategy 131
      • 11.6.4 Key Developments 131
    • 11.7 Koninklijke Philips N.V. 132
      • 11.7.1 Financials 132
      • 11.7.2 Products 132
      • 11.7.3 Strategy 132
      • 11.7.4 Key Developments 132
    • 11.8 LG Electronics 133
      • 11.8.1 Financials 133
      • 11.8.2 Products 133
      • 11.8.3 Strategy 133
      • 11.8.4 Key Developments 133
    • 11.9 Fresenius SE & Co KGaA 134
      • 11.9.1 Financials 134
      • 11.9.2 Products 134
      • 11.9.3 Strategy 134
      • 11.9.4 Key Developments 134
    • 11.10 McKesson Corporation 135
      • 11.10.1 Financials 135
      • 11.10.2 Products 135
      • 11.10.3 Strategy 135
      • 11.10.4 Key Developments 135
    • 11.11 F. Hoffmann-La Roche AG 136
      • 11.11.1 Financials 136
      • 11.11.2 Products 136
      • 11.11.3 Strategy 136
      • 11.11.4 Key Developments 136
    • 11.12 B. Braun Melsungen AG 137
      • 11.12.1 Financials 137
      • 11.12.2 Products 137
      • 11.12.3 Strategy 137
      • 11.12.4 Key Developments 137
    • 11.13 3M 138
      • 11.13.1 Financials 138
      • 11.13.2 Products 138
      • 11.13.3 Strategy 138
      • 11.13.4 Key Developments 138
    • 11.14 A&D Company 139
      • 11.14.1 Financials 139
      • 11.14.2 Products 139
      • 11.14.3 Strategy 139
      • 11.14.4 Key Developments 139
    • 11.15 Kinnser Software 140
      • 11.15.1 Financials 140
      • 11.15.2 Products 140
      • 11.15.3 Strategy 140
      • 11.15.4 Key Developments 140

    12 Conclusion 141

    • 12.1 Key Findings 142
      • 12.1.1 From CEO’s View Point 142

    13 Appendix 143

    • 13.1 Discussion Blue Print 144

    Report You Might be Interested

    Keywords